Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.06
AMN's Cash-to-Debt is ranked lower than
79% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. AMN: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
AMN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.06 Max: 32.76
Current: 0.06
0
32.76
Equity-to-Asset 0.45
AMN's Equity-to-Asset is ranked lower than
59% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. AMN: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
AMN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.39 Max: 0.88
Current: 0.45
0.25
0.88
Debt-to-Equity 0.60
AMN's Debt-to-Equity is ranked lower than
52% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. AMN: 0.60 )
Ranked among companies with meaningful Debt-to-Equity only.
AMN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.71 Max: 1.84
Current: 0.6
0
1.84
Debt-to-EBITDA 1.33
AMN's Debt-to-EBITDA is ranked higher than
71% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. AMN: 1.33 )
Ranked among companies with meaningful Debt-to-EBITDA only.
AMN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.64  Med: 1.74 Max: 3.8
Current: 1.33
-7.64
3.8
Interest Coverage 9.81
AMN's Interest Coverage is ranked higher than
57% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. AMN: 9.81 )
Ranked among companies with meaningful Interest Coverage only.
AMN' s Interest Coverage Range Over the Past 10 Years
Min: 1.59  Med: 6.76 Max: 16.54
Current: 9.81
1.59
16.54
Piotroski F-Score: 4
Altman Z-Score: 4.47
Beneish M-Score: -2.52
WACC vs ROIC
5.45%
16.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 10.62
AMN's Operating Margin % is ranked higher than
62% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. AMN: 10.62 )
Ranked among companies with meaningful Operating Margin % only.
AMN' s Operating Margin % Range Over the Past 10 Years
Min: -20.22  Med: 6.06 Max: 10.62
Current: 10.62
-20.22
10.62
Net Margin % 5.99
AMN's Net Margin % is ranked higher than
60% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. AMN: 5.99 )
Ranked among companies with meaningful Net Margin % only.
AMN' s Net Margin % Range Over the Past 10 Years
Min: -16.08  Med: 2.98 Max: 5.99
Current: 5.99
-16.08
5.99
ROE % 24.53
AMN's ROE % is ranked higher than
90% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. AMN: 24.53 )
Ranked among companies with meaningful ROE % only.
AMN' s ROE % Range Over the Past 10 Years
Min: -53.71  Med: 13.25 Max: 27.1
Current: 24.53
-53.71
27.1
ROA % 9.90
AMN's ROA % is ranked higher than
83% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. AMN: 9.90 )
Ranked among companies with meaningful ROA % only.
AMN' s ROA % Range Over the Past 10 Years
Min: -23.68  Med: 5.28 Max: 10.49
Current: 9.9
-23.68
10.49
ROC (Joel Greenblatt) % 89.09
AMN's ROC (Joel Greenblatt) % is ranked higher than
87% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. AMN: 89.09 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AMN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -137.1  Med: 48.55 Max: 89.09
Current: 89.09
-137.1
89.09
3-Year Revenue Growth Rate 22.20
AMN's 3-Year Revenue Growth Rate is ranked higher than
88% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. AMN: 22.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AMN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -18.7  Med: 7.9 Max: 22.2
Current: 22.2
-18.7
22.2
3-Year EBITDA Growth Rate 39.50
AMN's 3-Year EBITDA Growth Rate is ranked higher than
89% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. AMN: 39.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AMN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -22.7  Med: 18.8 Max: 91.3
Current: 39.5
-22.7
91.3
3-Year EPS without NRI Growth Rate 46.10
AMN's 3-Year EPS without NRI Growth Rate is ranked higher than
87% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. AMN: 46.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AMN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -52.4  Med: 23.7 Max: 139.6
Current: 46.1
-52.4
139.6
GuruFocus has detected 5 Warning Signs with AMN Healthcare Services Inc AMN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AMN's 30-Y Financials

Financials (Next Earnings Date: 2018-02-16)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

AMN Guru Trades in Q4 2016

Chuck Royce 110,600 sh (New)
Columbia Wanger 706,642 sh (+47.19%)
Joel Greenblatt 130,427 sh (+40.23%)
Ken Heebner 260,000 sh (+30.00%)
Paul Tudor Jones 6,452 sh (-73.15%)
» More
Q1 2017

AMN Guru Trades in Q1 2017

Steven Cohen 77,293 sh (New)
Chuck Royce 406,964 sh (+267.96%)
Joel Greenblatt 326,601 sh (+150.41%)
Paul Tudor Jones 10,546 sh (+63.45%)
Columbia Wanger 391,545 sh (-44.59%)
Ken Heebner 70,000 sh (-73.08%)
» More
Q2 2017

AMN Guru Trades in Q2 2017

Jim Simons 86,200 sh (New)
Third Avenue Management 73,842 sh (New)
Chuck Royce 1,074,684 sh (+164.07%)
Columbia Wanger 928,097 sh (+137.03%)
Joel Greenblatt 389,369 sh (+19.22%)
Ken Heebner Sold Out
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
» More
Q3 2017

AMN Guru Trades in Q3 2017

Third Avenue Management 143,642 sh (+94.53%)
Jim Simons Sold Out
Columbia Wanger 922,387 sh (-0.62%)
Joel Greenblatt 311,936 sh (-19.89%)
Chuck Royce 733,444 sh (-31.75%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:AMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-09-30 Reduce -19.89%0.04%$35.55 - $45.45 $ 44.3016%311,936
Third Avenue Management 2017-09-30 Add 94.53%0.15%$35.55 - $45.45 $ 44.3016%143,642
Joel Greenblatt 2017-06-30 Add 19.22%0.03%$35.4 - $41.95 $ 44.3015%389,369
Third Avenue Management 2017-06-30 New Buy0.13%$35.4 - $41.95 $ 44.3015%73,842
Ken Heebner 2017-06-30 Sold Out 0.13%$35.4 - $41.95 $ 44.3015%0
Joel Greenblatt 2017-03-31 Add 150.41%0.1%$35.6 - $43.2 $ 44.3013%326,601
Ken Heebner 2017-03-31 Reduce -73.08%0.32%$35.6 - $43.2 $ 44.3013%70,000
Ken Heebner 2016-12-31 Add 30.00%0.1%$26.9 - $39.6 $ 44.3030%260,000
Joel Greenblatt 2016-12-31 Add 40.23%0.02%$26.9 - $39.6 $ 44.3030%130,427
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8361
Compare:ISX:MIKA, SAU:4002, NAS:LPNT, JSE:LHC, NSE:APOLLOHOSP, OSTO:ATT, XTER:RHK, NAS:TVTY, HKSE:01515, JSE:NTC, NAS:AMED, SAU:4004, NYSE:SEM, LSE:SPI, XSGO:BANMEDICA, SGX:BSL, ASX:HSO, ASX:PRY, NYSE:THC, TSE:7716 » details
Traded in other countries:HCQ.Germany,
Headquarter Location:USA
AMN Healthcare Services Inc is a healthcare staffing firm. It provides healthcare workforce solutions and staffing services. AMN provides nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services.

AMN Healthcare Services is the largest healthcare staffing firm in the United States. In 2016, it placed well over 8,500 nurses and allied healthcare workers with provider clients nationwide. About two thirds of its business is generated from its temporary nursing division, and the other third is generated from its temporary and permanent placement physician divisions.

Guru Investment Theses on AMN Healthcare Services Inc

Third Avenue Comments on AMN Healthcare Services - Jul 27, 2017

AMN Healthcare Services (NYSE:AMN)



Founded in 1985 as a travel nursing company, AMN has become a leading healthcare staffing company that offers temporary placement of healthcare professionalsfor hospitals to fulfill various durations ranging from one day to 2 years. Since 2013, the company spent a total of $360MM on several acquisitions to enter the "solutions" business (outsourced recruiting, permanent staffing, managing personnel, and software scheduling for hospitals) to extend its portfolio. In terms of profit drivers, travelling nurses and allied healthcare workers contribute about 55% of pre-overhead EBITDA, while temporary physicians and the new Solutions segments contribute approximately 20% and 26%, respectively.



In its core business, which is filling staff shortages, AMN providesthe crucial exchange between demand and supply. Hospitalsneed an intermediary such as AMN to find healthcare workers, vet their credentials, handle all administrative tasks, make payments, and provide workers' comp and medical malpractice insurance. Healthcare professionalsneed a source to find work, arrange travelling, and receive weekly or biweekly paychecks.



While it does not command the same level of operational leverage as international networks such as eBay, Facebook, or Uber, AMN's economics do significantly improve as it becomeslarger. As AMN further expands into Solutions and integrates itself into hospitals' staffing functions (MSP or Managed Service Provider), it further enhancesits market position and cements its relationship with its clients.



We think AMN is benefiting both from positive demographic trends, which provide good growth, and margin expansion. Beyond the Affordable Healthcare Act that increased the insured population by about 20 million people, the aging population and the shortage of healthcare professionals will create strong demand for temporary staffing services. Benefiting from operational leverage, management expects operating margins will continue to expand. With the high level and growing free cash flow, we think AMN common shares have 30% potential upside to our NAV target.



From Third Avenue Small-Cap Fund's second quarter 2017 shareholder letter.



Check out Third Avenue Management,Martin Whitman latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 18.54
AMN's PE Ratio is ranked higher than
69% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. AMN: 18.54 )
Ranked among companies with meaningful PE Ratio only.
AMN' s PE Ratio Range Over the Past 10 Years
Min: 6.08  Med: 19.09 Max: 68.31
Current: 18.54
6.08
68.31
Forward PE Ratio 15.72
AMN's Forward PE Ratio is ranked higher than
67% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. AMN: 15.72 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 18.54
AMN's PE Ratio without NRI is ranked higher than
70% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. AMN: 18.54 )
Ranked among companies with meaningful PE Ratio without NRI only.
AMN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 6.08  Med: 20.34 Max: 64.62
Current: 18.54
6.08
64.62
Price-to-Owner-Earnings 22.16
AMN's Price-to-Owner-Earnings is ranked higher than
65% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. AMN: 22.16 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AMN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.81  Med: 19.81 Max: 332.38
Current: 22.16
4.81
332.38
PB Ratio 3.98
AMN's PB Ratio is ranked lower than
75% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. AMN: 3.98 )
Ranked among companies with meaningful PB Ratio only.
AMN' s PB Ratio Range Over the Past 10 Years
Min: 0.75  Med: 2.67 Max: 5.83
Current: 3.98
0.75
5.83
PS Ratio 1.11
AMN's PS Ratio is ranked higher than
64% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. AMN: 1.11 )
Ranked among companies with meaningful PS Ratio only.
AMN' s PS Ratio Range Over the Past 10 Years
Min: 0.14  Med: 0.57 Max: 1.4
Current: 1.11
0.14
1.4
Price-to-Free-Cash-Flow 17.94
AMN's Price-to-Free-Cash-Flow is ranked higher than
64% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. AMN: 17.94 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AMN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.96  Med: 14.93 Max: 127.46
Current: 17.94
1.96
127.46
Price-to-Operating-Cash-Flow 15.26
AMN's Price-to-Operating-Cash-Flow is ranked lower than
53% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. AMN: 15.26 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AMN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.86  Med: 12.48 Max: 1087.5
Current: 15.26
1.86
1087.5
EV-to-EBIT 11.56
AMN's EV-to-EBIT is ranked higher than
80% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. AMN: 11.56 )
Ranked among companies with meaningful EV-to-EBIT only.
AMN' s EV-to-EBIT Range Over the Past 10 Years
Min: -17.7  Med: 11.8 Max: 26.7
Current: 11.56
-17.7
26.7
EV-to-EBITDA 10.05
AMN's EV-to-EBITDA is ranked higher than
71% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. AMN: 10.05 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -35.3  Med: 9.7 Max: 17.9
Current: 10.05
-35.3
17.9
EV-to-Revenue 1.23
AMN's EV-to-Revenue is ranked higher than
73% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. AMN: 1.23 )
Ranked among companies with meaningful EV-to-Revenue only.
AMN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.2  Med: 0.8 Max: 1.6
Current: 1.23
0.2
1.6
PEG Ratio 0.59
AMN's PEG Ratio is ranked higher than
89% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. AMN: 0.59 )
Ranked among companies with meaningful PEG Ratio only.
AMN' s PEG Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.2 Max: 2.83
Current: 0.59
0.36
2.83
Shiller PE Ratio 167.46
AMN's Shiller PE Ratio is ranked lower than
96% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. AMN: 167.46 )
Ranked among companies with meaningful Shiller PE Ratio only.
AMN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.67  Med: 192.14 Max: 3524
Current: 167.46
27.67
3524
Current Ratio 1.81
AMN's Current Ratio is ranked higher than
61% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. AMN: 1.81 )
Ranked among companies with meaningful Current Ratio only.
AMN' s Current Ratio Range Over the Past 10 Years
Min: 1.42  Med: 1.88 Max: 4.28
Current: 1.81
1.42
4.28
Quick Ratio 1.81
AMN's Quick Ratio is ranked higher than
64% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. AMN: 1.81 )
Ranked among companies with meaningful Quick Ratio only.
AMN' s Quick Ratio Range Over the Past 10 Years
Min: 1.42  Med: 1.88 Max: 4.28
Current: 1.81
1.42
4.28
Days Sales Outstanding 70.65
AMN's Days Sales Outstanding is ranked lower than
83% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. AMN: 70.65 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.99  Med: 65.58 Max: 82.03
Current: 70.65
42.99
82.03
Days Payable 6.65
AMN's Days Payable is ranked lower than
93% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. AMN: 6.65 )
Ranked among companies with meaningful Days Payable only.
AMN' s Days Payable Range Over the Past 10 Years
Min: 6.65  Med: 10.47 Max: 19.05
Current: 6.65
6.65
19.05

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.10
AMN's 3-Year Average Share Buyback Ratio is ranked higher than
64% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. AMN: -1.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.9  Med: -4.95 Max: 12.5
Current: -1.1
-11.9
12.5

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.74
AMN's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
54% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. AMN: 1.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AMN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.2  Med: 1 Max: 3.04
Current: 1.74
0.2
3.04
Price-to-Median-PS-Value 1.95
AMN's Price-to-Median-PS-Value is ranked lower than
91% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. AMN: 1.95 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AMN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.26  Med: 1.27 Max: 3.83
Current: 1.95
0.26
3.83
Price-to-Peter-Lynch-Fair-Value 0.74
AMN's Price-to-Peter-Lynch-Fair-Value is ranked higher than
91% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.11 vs. AMN: 0.74 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AMN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.47  Med: 1.18 Max: 2.75
Current: 0.74
0.47
2.75
Earnings Yield (Greenblatt) % 8.65
AMN's Earnings Yield (Greenblatt) % is ranked higher than
85% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. AMN: 8.65 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AMN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -45.6  Med: 7.3 Max: 20.4
Current: 8.65
-45.6
20.4
Forward Rate of Return (Yacktman) % 38.70
AMN's Forward Rate of Return (Yacktman) % is ranked higher than
92% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. AMN: 38.70 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AMN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 3.5  Med: 20.2 Max: 39.9
Current: 38.7
3.5
39.9

More Statistics

Revenue (TTM) (Mil) $1,967.24
EPS (TTM) $ 2.39
Beta0.56
Short Percentage of Float26.25%
52-Week Range $31.96 - 46.60
Shares Outstanding (Mil)47.77

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 1,995 2,135 2,318
EPS ($) 2.55 2.82 3.04
EPS without NRI ($) 2.55 2.82 3.04
EPS Growth Rate
(Future 3Y To 5Y Estimate)
-27.03%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for NYSE:AMN

Headlines

Articles On GuruFocus.com

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}